Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Hachulla

Showing results (411-420 of 506) with videos related to

Pageof 51
Sort By:
Rheumatology (Oxford, England)|June 17, 2026
Gastrointestinal involvement in dermatomyositis: multicentric retrospective cohort studyOrane Demuynck, Camille Rasmussen, Mohamed-Yacine Khitri, et al.
Seminars in Arthritis and Rheumatism|February 18, 2021
Granulomatosis with polyangiitis: Study of 795 patients from the French Vasculitis Study Group registryMichele Iudici, Christian Pagnoux, Delphine S Courvoisier, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 15, 2018
C-Reactive protein as a diagnostic tool in differential diagnosis of hypereosinophilic syndrome and antineutrophil cytoplasmic antibody-negative eosinophilic granulomatosis with polyangiitisAmélie Leurs, Cécile Chenivesse, Benjamin Lopez, et al.
Annals of the Rheumatic Diseases|December 25, 2012
Efficacy of rituximab in systemic manifestations of primary Sjogren's syndrome: results in 78 patients of the AutoImmune and Rituximab registryJacques-Eric Gottenberg, Gael Cinquetti, Claire Larroche, et al.
Joint Bone Spine|May 1, 2012
Abatacept therapy and safety managementThao Pham, Hervé Bachelez, Jean-Marie Berthelot, et al.
The Journal of Rheumatology|March 17, 2012
Independent replication and meta analysis of association studies establish TNFSF4 as a susceptibility gene preferentially associated with the subset of anticentromere-positive patients with systemic sclerosisBaptiste Coustet, Matthieu Bouaziz, Philippe Dieudé, et al.
Arthritis and Rheumatism|August 29, 2013
A regulatory variant in CCR6 is associated with susceptibility to antitopoisomerase-positive systemic sclerosisEugénie Koumakis, Matthieu Bouaziz, Philippe Dieudé, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2020
Bortezomib, Melphalan, and Dexamethasone for Light-Chain AmyloidosisEfstathios Kastritis, Xavier Leleu, Bertrand Arnulf, et al.
The Lancet. Rheumatology|January 22, 2024
Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): open-label, long-term extension of a phase 2b, randomised, placebo-controlled trialOliver Distler, Yannick Allanore, Christopher P Denton, et al.
Rheumatology (Oxford, England)|December 13, 2016
A multicentre study of 95 biopsy-proven cases of renal disease in primary Sjögren's syndromeMagali Jasiek, Alexandre Karras, Véronique Le Guern, et al.
Pageof 51

Showing results (411-420 of 506) with videos related to

Sort By:
Pageof 51
Rheumatology (Oxford, England)|June 17, 2026
Gastrointestinal involvement in dermatomyositis: multicentric retrospective cohort studyOrane Demuynck, Camille Rasmussen, Mohamed-Yacine Khitri, et al.
Seminars in Arthritis and Rheumatism|February 18, 2021
Granulomatosis with polyangiitis: Study of 795 patients from the French Vasculitis Study Group registryMichele Iudici, Christian Pagnoux, Delphine S Courvoisier, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 15, 2018
C-Reactive protein as a diagnostic tool in differential diagnosis of hypereosinophilic syndrome and antineutrophil cytoplasmic antibody-negative eosinophilic granulomatosis with polyangiitisAmélie Leurs, Cécile Chenivesse, Benjamin Lopez, et al.
Annals of the Rheumatic Diseases|December 25, 2012
Efficacy of rituximab in systemic manifestations of primary Sjogren's syndrome: results in 78 patients of the AutoImmune and Rituximab registryJacques-Eric Gottenberg, Gael Cinquetti, Claire Larroche, et al.
Joint Bone Spine|May 1, 2012
Abatacept therapy and safety managementThao Pham, Hervé Bachelez, Jean-Marie Berthelot, et al.
The Journal of Rheumatology|March 17, 2012
Independent replication and meta analysis of association studies establish TNFSF4 as a susceptibility gene preferentially associated with the subset of anticentromere-positive patients with systemic sclerosisBaptiste Coustet, Matthieu Bouaziz, Philippe Dieudé, et al.
Arthritis and Rheumatism|August 29, 2013
A regulatory variant in CCR6 is associated with susceptibility to antitopoisomerase-positive systemic sclerosisEugénie Koumakis, Matthieu Bouaziz, Philippe Dieudé, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2020
Bortezomib, Melphalan, and Dexamethasone for Light-Chain AmyloidosisEfstathios Kastritis, Xavier Leleu, Bertrand Arnulf, et al.
The Lancet. Rheumatology|January 22, 2024
Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): open-label, long-term extension of a phase 2b, randomised, placebo-controlled trialOliver Distler, Yannick Allanore, Christopher P Denton, et al.
Rheumatology (Oxford, England)|December 13, 2016
A multicentre study of 95 biopsy-proven cases of renal disease in primary Sjögren's syndromeMagali Jasiek, Alexandre Karras, Véronique Le Guern, et al.
Pageof 51